Company intelligence / Profile preview

LPG Systems

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

LPG Systems’ endermologie platform is used globally for non-invasive medical and aesthetic indications. The technology’s effectiveness is backed by over 165 scientific studies, including 90 published on Medline, showing benefits for lymphatic drainage, cellulite reduction, scar and edema treatment, and facial rejuvenation[1][3][4][8].

Therapeutic areas: DermatologyNeurologyOtherCardiovascularHematology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on LPG Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LPG Systems.

Explore the full profile